查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1862165

藥品臨床試驗供給與物流：全球市佔率與排名、總收入及需求預測（2025-2031 年）

Clinical Trial Supply and Logistic for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 109 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球醫藥臨床試驗用品和物流市場在2024年達到 23.6億美元，預計到2031年將達到 40.66億美元，2025年至2031年的年複合成長率為 8.2%。

藥物臨床試驗供應與物流是一個專業的服務體系，為製藥公司、受託研究機構（CRO）和研究機構提供貫穿整個臨床試驗生命週期的藥物和物料的全面供應、儲存、配送和溫控運輸服務。這些服務包括生產後的臨床包裝、貼標、試劑盒組裝、批次追溯、全球供應鏈設計、清關、符合 GMP/GDP 標準的倉儲以及精準數位化供應鏈管理、智慧溫控解決方案和符合全球標準的網路，提供端到端、全程可追溯的服務，加速藥物研發到商業化的進程。

受藥物研發週期縮短和全球臨床試驗網路不斷擴展的推動，醫藥臨床試驗供應和物流行業正經歷前所未有的成長。精準醫療、細胞和基因療法、RNA藥物以及罕見疾病治療的快速發展，對供應鏈的靈活性、可追溯性和合規性提出了更高的要求。對數位化供應鏈解決方案、自動化倉庫和智慧運輸設備的投資，不僅提高了製藥公司的營運效率，也增強了其進入全球市場的管道。政府對醫藥創新的激勵措施和加速核准流程，促進業內跨境合作的標準化。

主要挑戰包括監管合規成本、國際物流的複雜性、資源分配壓力。嚴格的全球GMP/GDP標準和低溫運輸運輸需求需要持續投資於技術和專業人才。跨境臨床試驗進一步加劇了供應鏈協調的複雜性，而地緣政治的不確定性、公共衛生危機以及物流能力的波動則增加了營運風險。此外，對創新治療方法的小批量、大容量和快速回應供應模式的需求不斷成長，推高了成本，並提高了對供應鏈靈活性的需求。

隨著全球創新藥物研發管線的不斷擴展，臨床試驗的供應和物流需求正從基本的倉儲和運輸服務轉向全面的端到端解決方案。製藥公司、合約研究機構（CRO）和生技公司越來越重視合規透明度和即時供應鏈視覺性，以縮短研發週期並最佳化資源利用。精準醫療的進步推動對生物樣本物流、伴隨診斷和直接面向患者（DTP）的需求，促使業界朝著更資料驅動和個性化的服務方向發展。預計這一領域將與數位化臨床試驗平台和分散式試驗模式深度融合，並成為藥物研發的策略資產。

上游供應鏈由低溫運輸技術、專用包裝材料、運輸容器和數位化管理系統組成。領先的低溫運輸解決方案和智慧包裝供應商不斷創新，以確保藥物在儲存和運輸過程中的穩定性。高性能隔熱材料、智慧溫度感測器和一次性包裝已成為業界標準。同時，先進的供應鏈管理平台、自動化倉儲系統和追蹤技術的整合，增強了全生命週期供應鏈能力，並保障了全球臨床試驗專案的安全高效運作。

本報告目的是依地區/國家、類型和應用對全球醫藥臨床試驗用品和物流市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名。

本報告以收益為準，以2024年為基準年，對醫藥臨床試驗供應和物流市場規模、估計值和預測進行了闡述，並涵蓋了2020年至2031年的歷史資料和預測資料。報告採用定量和定性分析相結合的方法，幫助讀者制定業務/成長策略、評估市場競爭、分析自身在當前市場中的地位，並就醫藥臨床試驗供應和物流做出明智的商業決策。

市場區隔

公司

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

依類型

  • 物流與配送
  • 生產/包裝
  • 供應鏈管理
  • 其他

依應用

  • 第一階段
  • 第二階段
  • 第三階段

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Clinical Trial Supply and Logistic for Pharmaceutical was estimated to be worth US$ 2360 million in 2024 and is forecast to a readjusted size of US$ 4066 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Clinical Trial Supply and Logistic for Pharmaceutical refers to a specialized service system providing comprehensive drug and material supply, storage, distribution, and temperature-controlled transportation throughout the entire clinical trial lifecycle for pharmaceutical companies, contract research organizations (CROs), and research institutions. This service encompasses post-manufacturing clinical packaging, labeling, kit assembly, batch traceability, global supply chain design, customs clearance, GMP/GDP-compliant warehousing, and precise distribution. With increasing trial complexity and the growth of multi-center, cross-regional clinical studies, clinical trial supply and logistics have become essential in mitigating R&D risks, improving trial efficiency, and safeguarding patient safety. Through digitalized supply chain management, intelligent temperature-control solutions, and globally compliant networks, the sector offers end-to-end, fully traceable services that accelerate the path from drug development to commercialization.

The pharmaceutical clinical trial supply and logistics sector is experiencing unprecedented growth driven by shorter drug development cycles and the expansion of global clinical trial networks. The rapid advancement of precision medicine, cell and gene therapies, RNA-based drugs, and rare disease treatments is raising the bar for supply chain flexibility, traceability, and regulatory compliance. Investment in digitalized supply chain solutions, automated warehousing, and intelligent transport equipment not only enhances operational efficiency for pharmaceutical companies but also strengthens global market access. Government incentives for drug innovation and accelerated approval pathways are fostering standardized, cross-border collaboration within the industry.

Key challenges include regulatory compliance costs, the complexity of international logistics, and resource allocation pressures. Strict GMP/GDP standards and cold-chain transportation requirements worldwide necessitate continuous investments in technology and skilled personnel. Cross-border trials further complicate supply chain coordination, while geopolitical uncertainties, public health crises, and logistics capacity fluctuations heighten operational risks. Additionally, increasing demand for small-batch, multi-lot, rapid-response supply models for innovative therapies has driven up costs and supply chain agility requirements.

As the global pipeline of innovative drugs expands, the demand for clinical trial supply and logistics is shifting from basic storage and transport services to comprehensive end-to-end solutions. Pharmaceutical companies, CROs, and biotech firms increasingly prioritize compliance transparency and real-time supply chain visibility to shorten development timelines and optimize resource use. Precision medicine is driving demand for biological sample logistics, companion diagnostics, and direct-to-patient (DTP) delivery, pushing the industry toward more data-driven, personalized, and customized services. The sector is set to deeply integrate with digital clinical trial platforms and decentralized trial models, becoming a strategic asset in drug R&D.

The upstream supply chain comprises cold-chain technology, specialized packaging materials, transport containers, and digital management systems. Leading suppliers of cold-chain solutions and intelligent packaging continuously innovate to ensure drug stability during storage and transportation. High-performance insulation materials, smart temperature sensors, and single-use packaging have become standard in the industry. At the same time, the integration of advanced supply chain management platforms, automated warehousing systems, and tracking technologies strengthens lifecycle supply chain capabilities, ensuring secure and efficient operations for global clinical trial programs.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply and Logistic for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supply and Logistic for Pharmaceutical by region & country, by Type, and by Application.

The Clinical Trial Supply and Logistic for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply and Logistic for Pharmaceutical.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

Segment by Type

  • Logistics & Distribution
  • Manufacturing and Packaging
  • Supply Chain Management
  • Other

Segment by Application

  • Phase I
  • Phase II
  • Phase III

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supply and Logistic for Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Supply and Logistic for Pharmaceutical Product Introduction
  • 1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Trends & Drivers
    • 1.3.1 Clinical Trial Supply and Logistic for Pharmaceutical Industry Trends
    • 1.3.2 Clinical Trial Supply and Logistic for Pharmaceutical Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Challenges
    • 1.3.4 Clinical Trial Supply and Logistic for Pharmaceutical Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supply and Logistic for Pharmaceutical
  • 2.6 Clinical Trial Supply and Logistic for Pharmaceutical Market Competitive Analysis
    • 2.6.1 Clinical Trial Supply and Logistic for Pharmaceutical Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supply and Logistic for Pharmaceutical Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supply and Logistic for Pharmaceutical as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Logistics & Distribution
    • 3.1.2 Manufacturing and Packaging
    • 3.1.3 Supply Chain Management
    • 3.1.4 Other
  • 3.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type
    • 3.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Phase I
    • 4.1.2 Phase II
    • 4.1.3 Phase III
  • 4.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application
    • 4.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region
    • 5.1.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Profile
    • 7.1.2 Thermo Fisher Scientific Main Business
    • 7.1.3 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.1.4 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Scientific Recent Developments
  • 7.2 Catalent Pharma Solutions
    • 7.2.1 Catalent Pharma Solutions Profile
    • 7.2.2 Catalent Pharma Solutions Main Business
    • 7.2.3 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.2.4 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Catalent Pharma Solutions Recent Developments
  • 7.3 Almac Group
    • 7.3.1 Almac Group Profile
    • 7.3.2 Almac Group Main Business
    • 7.3.3 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.3.4 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Almac Group Recent Developments
  • 7.4 Parexel International
    • 7.4.1 Parexel International Profile
    • 7.4.2 Parexel International Main Business
    • 7.4.3 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.4.4 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Parexel International Recent Developments
  • 7.5 UDG Healthcare
    • 7.5.1 UDG Healthcare Profile
    • 7.5.2 UDG Healthcare Main Business
    • 7.5.3 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.5.4 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.5.5 UDG Healthcare Recent Developments
  • 7.6 PCI Services
    • 7.6.1 PCI Services Profile
    • 7.6.2 PCI Services Main Business
    • 7.6.3 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.6.4 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.6.5 PCI Services Recent Developments
  • 7.7 Marken
    • 7.7.1 Marken Profile
    • 7.7.2 Marken Main Business
    • 7.7.3 Marken Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.7.4 Marken Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Marken Recent Developments
  • 7.8 Klifo A/S.
    • 7.8.1 Klifo A/S. Profile
    • 7.8.2 Klifo A/S. Main Business
    • 7.8.3 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.8.4 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Klifo A/S. Recent Developments
  • 7.9 Walden Group
    • 7.9.1 Walden Group Profile
    • 7.9.2 Walden Group Main Business
    • 7.9.3 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.9.4 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Walden Group Recent Developments
  • 7.10 Bilcare Limited
    • 7.10.1 Bilcare Limited Profile
    • 7.10.2 Bilcare Limited Main Business
    • 7.10.3 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.10.4 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Bilcare Limited Recent Developments
  • 7.11 Biocair
    • 7.11.1 Biocair Profile
    • 7.11.2 Biocair Main Business
    • 7.11.3 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.11.4 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Supply and Logistic for Pharmaceutical Industrial Chain
  • 8.2 Clinical Trial Supply and Logistic for Pharmaceutical Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Supply and Logistic for Pharmaceutical Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Supply and Logistic for Pharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Supply and Logistic for Pharmaceutical Market Trends
  • Table 2. Clinical Trial Supply and Logistic for Pharmaceutical Market Drivers & Opportunity
  • Table 3. Clinical Trial Supply and Logistic for Pharmaceutical Market Challenges
  • Table 4. Clinical Trial Supply and Logistic for Pharmaceutical Market Restraints
  • Table 5. Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Supply and Logistic for Pharmaceutical
  • Table 10. Global Clinical Trial Supply and Logistic for Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supply and Logistic for Pharmaceutical as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Scientific Basic Information List
  • Table 32. Thermo Fisher Scientific Description and Business Overview
  • Table 33. Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Thermo Fisher Scientific (2020-2025)
  • Table 35. Thermo Fisher Scientific Recent Developments
  • Table 36. Catalent Pharma Solutions Basic Information List
  • Table 37. Catalent Pharma Solutions Description and Business Overview
  • Table 38. Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Catalent Pharma Solutions (2020-2025)
  • Table 40. Catalent Pharma Solutions Recent Developments
  • Table 41. Almac Group Basic Information List
  • Table 42. Almac Group Description and Business Overview
  • Table 43. Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Almac Group (2020-2025)
  • Table 45. Almac Group Recent Developments
  • Table 46. Parexel International Basic Information List
  • Table 47. Parexel International Description and Business Overview
  • Table 48. Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Parexel International (2020-2025)
  • Table 50. Parexel International Recent Developments
  • Table 51. UDG Healthcare Basic Information List
  • Table 52. UDG Healthcare Description and Business Overview
  • Table 53. UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of UDG Healthcare (2020-2025)
  • Table 55. UDG Healthcare Recent Developments
  • Table 56. PCI Services Basic Information List
  • Table 57. PCI Services Description and Business Overview
  • Table 58. PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of PCI Services (2020-2025)
  • Table 60. PCI Services Recent Developments
  • Table 61. Marken Basic Information List
  • Table 62. Marken Description and Business Overview
  • Table 63. Marken Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Marken (2020-2025)
  • Table 65. Marken Recent Developments
  • Table 66. Klifo A/S. Basic Information List
  • Table 67. Klifo A/S. Description and Business Overview
  • Table 68. Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Klifo A/S. (2020-2025)
  • Table 70. Klifo A/S. Recent Developments
  • Table 71. Walden Group Basic Information List
  • Table 72. Walden Group Description and Business Overview
  • Table 73. Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Walden Group (2020-2025)
  • Table 75. Walden Group Recent Developments
  • Table 76. Bilcare Limited Basic Information List
  • Table 77. Bilcare Limited Description and Business Overview
  • Table 78. Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Bilcare Limited (2020-2025)
  • Table 80. Bilcare Limited Recent Developments
  • Table 81. Biocair Basic Information List
  • Table 82. Biocair Description and Business Overview
  • Table 83. Biocair Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Biocair (2020-2025)
  • Table 85. Biocair Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Clinical Trial Supply and Logistic for Pharmaceutical Downstream Customers
  • Table 89. Clinical Trial Supply and Logistic for Pharmaceutical Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Supply and Logistic for Pharmaceutical Product Picture
  • Figure 2. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Supply and Logistic for Pharmaceutical Report Years Considered
  • Figure 5. Global Clinical Trial Supply and Logistic for Pharmaceutical Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Supply and Logistic for Pharmaceutical Revenue in 2024
  • Figure 7. Clinical Trial Supply and Logistic for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Logistics & Distribution Picture
  • Figure 9. Manufacturing and Packaging Picture
  • Figure 10. Supply Chain Management Picture
  • Figure 11. Other Picture
  • Figure 12. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Phase I
  • Figure 15. Product Picture of Phase II
  • Figure 16. Product Picture of Phase III
  • Figure 17. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (%), (2020-2031)
  • Figure 30. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Clinical Trial Supply and Logistic for Pharmaceutical Industrial Chain
  • Figure 52. Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed